Kappa Bioscience announced today that they have been granted novel food approval for their vitamin K2 as menaquinone-7 (K2VITALTM).
The Novel Food application was submitted to the German Food Safety Agency. Based on a positive German assessment, all the EU member states have acknowledged the novel food recommendation.
Kappa Bioscience is now ready to launch their K2VITAL™ product range in the European markets for food supplements, fortified foods and food products for specific nutritional purposes.
“This is a major achievement for all users of vitamin K2“, said CEO Egil Greve of Kappa Bioscience. “Our products represent a technological break-through in the vitamin sector and provide the market with vitamin K2 of the highest possible purity and functionality - for use in tablets, capsules and fortification of food products. This now allows food and DS manufactures to take vitamin K2 from a previous niche application into mainstream application due to a better cost-in-use proposition“, he added.
K2VITAL™ has been sold in the US and other selected markets since 2011. Kappa has a co-operation with Xsto Solutions for sales in the US DS segment and with DuPont, who acquired Danisco in May 2011, for the global food segment.
About Vitamin K2: Vitamin K is a group of fat soluble vitamins known to be critical in blood coagulation. Vitamin K is divided into K1 (clotting activity) and vitamin K2, which also has extra hepatic activities. Vitamin K2 as menaquinon-7 (MK-7) has the highest bioavailability and has proven effects on bone health (EFSA 13.1 Claim) and cardiovascular health. Vitamin K2 acts as co-factor for proteins involved in calcium metabolism.
K2VITAL™ is Kappa Bioscience’s commercial product range containing pure,
all-trans menaquinone-7 (MK-7). It is available in powder, granular and liquid form, each in various concentrations. K2VITAL™ is the most bio-available and cost effective form of vitamin K2 available for food and supplementation. This key nutrient offers significant health benefits for humans.
About Kappa Bioscience: Kappa Bioscience is the innovative leader and first mover within high purity, all-trans vitamin K2 as menaquinone-7 (MK-7). Kappa Bioscience is a Norwegian based entity with substantial resources and knowledge about vitamins and vitamin K2 in particular. Kappa Bioscience is currently the only vendor with vitamin K2 as pure MK-7 in various formulations, following a traditional vitamin production process with proprietary and innovative new steps. For further information, visit http://www.kappabio.com